The American Journal of Health Economics articles examine policies to address opioid crisis

SAN FRANCISCO — Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of the use of neoadjuvant chemotherapy, according to updated

A South Car­oli­na fed­er­al court on Fri­day en­dorsed the idea that the Health Re­sources and Ser­vices Ad­min­is­tra­tion’s de­f­i­n­i­tion of “pa­tient” un­der its 340B pro­gram for